Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Flu redux and RIT: Friendly fire in the treatment of low-grade lymphoma
Leo I. Gordon
Medicine, Hematology Oncology Division
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Flu redux and RIT: Friendly fire in the treatment of low-grade lymphoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Secondary Malignancy
100%
Redux
100%
Tositumomab
100%
Alkylating Agents
100%
Fludarabine
100%
Low-grade Lymphoma
100%
I-131
100%
Bexxar
100%
Friendly Fire
100%
Medicine and Dentistry
Non-Hodgkin Lymphoma
100%
Iodine 131
100%
Alkylating Antineoplastic Agent
100%
Fludarabine
100%
Tositumomab
100%
Dexfenfluramine
100%
Tositumomab I 131
100%
Cancer
100%
Pharmacology, Toxicology and Pharmaceutical Science
Tositumomab
100%
Iodine-131
100%
Nonhodgkin Lymphoma
100%
Alkylating Agent
100%
Tositumomab I 131
100%
Fludarabine
100%
Dexfenfluramine
100%